Ache Laboratorios Farmaceuticos S.A.

What Ache Laboratorios Farmaceuticos S.A. does

Ach\u00e9 Laborat\u00f3rios Farmac\u00eauticos S.A. is one of Brazil's five largest pharmaceutical companies, founded in 1966 and headquartered in Guarulhos, S\u00e3o Paulo. The company develops, manufactures, and markets a portfolio of more than 350 brands and 900+ presentations across 150+ therapeutic classes and 30 medical specialties, serving both prescription and over-the-counter segments through wholly-owned sub-brands including Biosint\u00e9tica (generics), Profuse, Essencele, Ensolei, Nutrel, Hidradeep, Puriance, Sembl\u00e9, and Clair (dermo/nutricosmetics). Operations are anchored by four domestic manufacturing plants (Guarulhos, An\u00e3polis, Cabo de Santo Agostinho, Jurubatuba), a 3,000-vehicle distribution fleet, and an R&D base supported by BRL 153 million in annual innovation spend, 193 active development projects (including 13 radical innovation and 8 Bioprospera biodiversity programs), and collaborations with CNPEM's Sirius particle accelerator and the Bionovis biopharma joint venture.

The business is monetized primarily through physical-product sales to a diversified end market: a 6,000+ employee direct sales force targets healthcare professionals across an 85,000+ retail point network of pharmacies and drugstores, while the Brazilian government's Farm\u00e1cia Popular program delivers subsidized medications to the population via Ach\u00e9 products. Ancillary revenue and engagement channels include the Cuidados Pela Vida patient platform (discounts and health education), the Compre com Ach\u00e9 B2B pharmacy portal, Productive Development Partnerships with Bio-Manguinhos for biotech and biosimilars, and a 25% stake in Bionovis S.A. for high-complexity biologicals (Infliximab, Rituximab, Trastuzumab and others). The company holds a Fitch AAA (bra) / BB+ global credit rating and ISO 45001, 14001, and 50001 certifications.

Go-to-market spans both an enterprise field-sales motion targeting healthcare professionals and pharmacies and a sales-led consumer engagement motion through Cuidadospelavida.com.br and OTC channels. Ach\u00e9 reports a presence in 20+ countries and has recently (2025) launched consumer digital initiatives such as the 'Nossa Mente' mental-health platform and achieved Scope 1+2 carbon neutrality, while announcing a R$267 million expansion of its Pernambuco (Suape) sterile-injectables plant. Strategic communications emphasize open innovation via 750+ startup partnerships and recognition in the Top 10 of the 100 Open Startups ranking.

Name

Ache Laboratorios Farmaceuticos S.A.

Legal name

Aché Laboratórios Farmacêuticos S.A.

Website

https://ache.com.br

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Ach\u00e9 Laborat\u00f3rios Farmac\u00eauticos S.A. is one of Brazil's top 5 pharmaceutical companies, developing, manufacturing, and marketing 350+ brands across 150+ therapeutic classes from four domestic plants and serving patients, healthcare professionals, and retail pharmacies through an 85,000+ point distribution network.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

akta.pro secondary industries

Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG), Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

Keywords

• Prescription pharmaceuticals
• Generic medications
• Over-the-counter drugs
• Dermocosmetic products
• Biopharmaceutical products

Headquarters

HQ city

Guarulhos

HQ country

Brazil

HQ region

Latin America

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Core revenue from manufacturing and selling prescription and over-the-counter pharmaceutical products through pharmacies, drugstores, and healthcare institutions. Portfolio of 350+ brands across 900+ presentations.
2. Government Channel - Farmácia Popular: Sales through Brazilian government Farmácia Popular program providing subsidized medications to population, targeting government healthcare institutions and public pharmacies.
3. Patient Support Programs: Revenue from Cuidadospelavida.com.br patient support and discount program, providing medication access support and loyalty benefits to patients.
4. Product Licensing and PDP: Revenue from Product Development Partnerships (PDP) with government entities like Bio-Manguinhos for biotech and generic medications.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Aché Laboratórios Farmacêuticos S.A. develops, manufactures, and markets pharmaceutical products in Brazil, with a portfolio of 350+ brands and 900+ presentations across 150+ therapeutic classes and 30 medical specialties. Products include prescription medications, over-the-counter (OTC) drugs, generic pharmaceuticals, dermocosmetic lines, dietary supplements, and hormonal products, manufactured at four plants and distributed through 85,000+ sales points including pharmacies, drugstores, and the government Farmácia Popular program. The company also engages in biotechnology through its Bionovis joint venture and pursues innovation via the Bioprospera biodiversity platform and Sirius particle accelerator research partnership.

Differentiator

Problem solved

Functional benefit

Brands

• Biosintética: Brand for generic pharmaceutical products including prescription generics, OTC generics, and dietary supplements
• Cuidados Pela Vida
• Cuidados Pela Vida (Farmácia Popular)
• Compre com Aché
• Bionovis
• Inovação Aberta Aché
• Profuse
• Essencele
• Ensolei
• Nutrel
• Hidradeep
• Puriance
• Semblé
• Clair
• Bioprospera

Products and services

• Aché Prescription Medications Prescription-only pharmaceutical products under the Aché master brand covering cardiovascular, musculoskeletal, respiratory, and other therapeutic areas, sold to patients through pharmacies on physician prescription.
• Aché Over-the-Counter (OTC) Medications OTC medications under the Aché brand available without prescription for common health conditions, sold through pharmacies and drugstores to end consumers.
• Biosintética Generic Pharmaceuticals Generic pharmaceutical products under the Biosintética sub-brand, including prescription generics, OTC generics, and dietary supplements, distributed through pharmacies across Brazil.
• Aché Dermocosmetic and Nutricosmetic Lines (Profuse, Essencele, Ensolei, Nutrel, Hidradeep, Puriance, Semblé, Clair) Dermocosmetic product lines including Profuse (skin, body, hair), Essencele (anti-aging with hyaluronic acid, vitamin C, retinol), Ensolei (sunscreen), Nutrel (sensitive skin), Hidradeep (hydration), Puriance (acne-prone/oily), Semblé (collagen, biotin, lutein supplements), and Clair (skin lightening), sold through pharmacies to consumers.
• Aché Dietary Supplements and Hormonal Products Dietary supplements and hormonal pharmaceutical products under the Aché brand categories, sold through pharmacies to patients and consumers.
• Bionovis Biopharmaceutical Products Biological drugs and biosimilars developed and produced through the Bionovis S.A. joint venture (25% Aché stake), including Infliximab, Rituximab, Trastuzumab, Etanercept, Golimumab, and Betainterferona 1a, supplied to the Brazilian public health system through Productive Development Partnerships.
• Farmácia Popular Subsidized Medication Program Aché's participation in Brazil's Farmácia Popular government program, providing 100% subsidized medications (free) or with 90% discount to the population through partner pharmacies and public outlets.
• Cuidados Pela Vida Patient Support Program Patient and healthcare professional support platform (Cuidadospelavida.com.br) offering health information, discount programs, and product access support to enrolled patients and clinicians.

Quantifiable outcome

• 5th largest pharmaceutical company in Brazil by market share
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• BionoviscoreStrategic or Co-development PartnerJoint venture with other 3 Brazilian pharmaceutical laboratories to develop and manufacture biotech medications and biosimilars, strengthening local biotech capabilities.
• Bio-ManguinhoscoreStrategic or Co-development PartnerProduct Development Partnership (PDP) for developing and manufacturing biotech medications for Brazilian public health system, leveraging government collaboration.
• PhytobiosminorStrategic or Co-development PartnerPartnership focused on herbal and natural medicine development utilizing Brazilian biodiversity through the Bioprospera platform.
• CNPEM (Sirius Accelerator)coreTechnology or IntegrationCollaboration with National Center for Research in Energy and Materials for access to Sirius particle accelerator for advanced pharmaceutical research and development.
• Achilles InternationalminorGTM or Marketing PartnerSponsorship partnership supporting athletic program with 53 team members (20 athletes, 28 guides, 5 coordinators) for sports sponsorship and brand visibility.
• Deusdará FilmesminorStrategic or Co-development PartnerPartnership for developing Nossa Mente platform, a mental health and wellness digital initiative.
• Atiaia RenováveisminorStrategic or Co-development PartnerPartnership for photovoltaic renewable energy plant in Goiana, Pernambuco supporting carbon neutrality and sustainable manufacturing operations.
• WayCarbonminorImplementation/ SI/ Consulting PartnerCarbon neutrality consulting partnership providing expertise and guidance for achieving and maintaining carbon neutral status.
• Fundação Dorina Nowill para CegosminorStrategic or Co-development PartnerPRONAC project partnership supporting accessibility for visually impaired individuals through product and service adaptations.
• Innovation Startup EcosystemcoreStrategic or Co-development PartnerActive engagement with 750+ startups through open innovation programs, hackathons, and collaborative development projects to drive digital transformation and new product development.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• EMS Farmacêutica: Brazil's largest pharmaceutical company by units sold, with leading positions in generics, branded, and OTC; directly comparable to Aché in pharmacy distribution scale, therapeutic-class breadth, and government-channel participation.
• Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with a broad branded and generic portfolio across multiple therapeutic areas; one of the largest domestic players and a direct competitor to Aché in retail pharmacy and prescription channels.
• Hypera Pharma (Hyperapharma): Top-tier Brazilian pharmaceutical company with broad prescription, OTC, generics, and consumer-health portfolio; competes head-to-head with Aché across multiple therapeutic classes and shares similar pharmacy-distribution-led GTM.
• Medley (Sanofi): Brazilian generics and branded prescription business now part of Sanofi; comparable to Aché's Biosintética generic arm and competes directly in retail pharmacy channels.
• Libbs Farmacêutica: Privately-held Brazilian pharmaceutical company with branded prescription, oncology, and women's-health focus; comparable to Aché in mid-tier branded positioning and Brazilian retail-pharmacy GTM.
• Biolab Farmacêutica: Mid-to-large Brazilian pharmaceutical company with branded prescription and OTC focus; competes with Aché in similar therapeutic categories and shares Brazil-centric distribution model.

Broad incumbents

• Novartis: Global pharmaceutical major with Brazilian commercial footprint in cardiology, oncology, and immunology; provides competitive benchmark for branded specialty therapeutics in the same prescription categories Aché targets.
• Roche: Global biopharmaceutical incumbent with strong oncology and specialty presence in Brazil; competes with Aché in hospital channels and increasingly in specialty prescriptions.
• Pfizer: Global pharmaceutical leader with significant Brazilian operations in branded prescription and vaccines; competes with Aché in major therapeutic classes and sets pricing benchmarks in the Brazilian market.

Regional players

• Cristália Produtos Químicos Farmacêuticos: Brazilian pharmaceutical manufacturer focused on hospital-use and specialty medicines including sterile injectables; comparable to Aché's Bionovis biopharma and Suape sterile-manufacturing expansion ambitions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/achelab
• Facebookpt-br.facebook.com/achelaboratorios
• LinkedInlinkedin.com/company/ache-laboratorios
• Instagraminstagram.com/ache.oficial

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ache Laboratorios Farmaceuticos S.A.